+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Expanded clinical spectrum of enhanced S-cone syndrome

Expanded clinical spectrum of enhanced S-cone syndrome

JAMA Ophthalmology 131(10): 1324-1330

New funduscopic findings in patients with enhanced S-cone syndrome (ESCS) may help clinicians in diagnosing this rare autosomal recessive retinal dystrophy. To expand the clinical spectrum of ESCS due to mutations in the NR2E3 gene. Retrospective, noncomparative case series of 31 patients examined between 1983 and 2012. Academic and private ophthalmology practices specialized in retinal dystrophies. A cohort of patients diagnosed with ESCS and harboring known NR2E3 mutations. Patients had ophthalmic examinations including visual function testing that led to the original diagnosis. New fundus features captured with imaging modalities. New clinical observations in ESCS include (1) torpedo-like, deep atrophic lesions with a small hyperpigmented rim, variably sized and predominantly located along the arcades; (2) circumferential fibrotic scars in the posterior pole with a spared center and large fibrotic scars around the optic nerve head; and (3) yellow dots in areas of relatively normal-appearing retina. Enhanced S-cone syndrome has more pleiotropy than previously appreciated. While the nummular type of pigmentation at the level of the retinal pigment epithelium and cystoid or schisis-like maculopathy with typical functional findings remain classic hallmarks of the disease, changes such as circumferential fibrosis of the macula or peripapillary area and "torpedo-like" lesions along the vascular arcades may also direct the clinical diagnosis and focus on screening the NR2E3 gene for a molecular diagnosis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053121926

Download citation: RISBibTeXText

PMID: 23989059

DOI: 10.1001/jamaophthalmol.2013.4349

Related references

Enhanced S-cone syndrome: Clinical spectrum in Indian population. Indian Journal of Ophthalmology 67(4): 523-529, 2019

Peripheral Cone Dystrophy: Expanded Clinical Spectrum, Multimodal and Ultrawide-Field Imaging, and Genomic Analysis. Journal of Ophthalmology 2018: 2984934, 2018

Expanded clinical spectrum of spondylocarpotarsal synostosis syndrome. 2008

S cone-driven but not S cone-type electroretinograms in the enhanced S cone syndrome. Experimental Eye Research 53(5): 685-690, 1991

Expanded Clinical Spectrum Of Multiple Evanescent White Dot Syndrome With Multimodal Imaging. Retina 36(1): 64-74, 2016

Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum. American Journal of Medical Genetics. Part a 155a(8): 1917-1922, 2011

Expanded clinical spectrum of spondylocarpotarsal synostosis syndrome and possible manifestation in a heterozygous father. American Journal of Medical Genetics. Part a 146a(6): 779-783, 2008

Clinical and molecular characterization of enhanced S-cone syndrome in children. JAMA Ophthalmology 132(11): 1341-1349, 2014

Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. American Journal of Ophthalmology 110(2): 124-134, 1990

Cone Vision Changes in the Enhanced S-Cone Syndrome Caused by NR2E3 Gene Mutations. Investigative Ophthalmology and Visual Science 59(8): 3209-3219, 2018

Response properties of the s blue cone mediated erg in the enhanced s cone syndrome. Investigative Ophthalmology & Visual Science 32(4): 1138, 1991

A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome. Plos Genetics 1(2): E11-E11, 2005

Vision in observers with enhanced S-cone syndrome: an excess of s-cones but connected mainly to conventional s-cone pathways. Investigative Ophthalmology and Visual Science 55(2): 963-976, 2014

Cone deactivation kinetics and GRK1/GRK7 expression in enhanced S cone syndrome caused by mutations in NR2E3. Investigative Ophthalmology & Visual Science 44(3): 1268-1274, 2003

Topography of cone electrophysiology in the enhanced S cone syndrome. Investigative Ophthalmology & Visual Science 40(8): 1866-1873, 1999